GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 251 - 275 of 4050 in total
Antibody Patient Onset (days) ▲ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 3 -180 mild
G84224TW
56
IgG Patient 3 -180 mild
G86156UJ
32
IgG Patient 3 -180 mild
G86541PE
45
IgG Patient 3 -180 mild
G86566MF
41
IgG Patient 3 -180 mild
G89993FE
41
IgG Patient 3 -180 mild
G90223GH
39
IgG Patient 3 -180 mild
G90562PB
109
IgG Patient 3 -180 mild
G91237TK
14141
IgG Patient 3 -180 mild
G91537AT
46
IgG Patient 3 -180 mild
G92022ML
46
IgG Patient 3 -180 mild
G92823JK
51
IgG Patient 3 -180 mild
G93351GM
39
IgG Patient 3 -180 mild
G94435QH
50
IgG Patient 3 -180 mild
G94576MN
49
IgG Patient 3 -180 mild
G96557TJ
48
IgG Patient 3 -180 mild
G96865DJ
1458
IgG Patient 3 -180 mild
G96881BQ
65
IgG Patient 3 -180 mild
G98068PA
2991
IgG Patient 3 -180 mild
G98240FC
54
IgG Patient 3 -180 mild
G99603GB
7170
IgM Patient 3 -180 mild
G00048MO
67
IgM Patient 3 -180 mild
G00051MO
129
IgM Patient 3 -180 mild
G00052MO
94
IgM Patient 3 -180 mild
G00053MO
63
IgM Patient 3 -180 mild
G00054MO
75

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024